ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
Awakn Life Sciences Initiates New Chemical Entity Development Program with Evotec as Research Partner and Addiction Expert, Prof. David Nutt, as Program Lead Company News
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Champignon Brands Inc. Psychedelics Investing
EBON, DOX & SHRMF Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
Lobe Sciences Enters into Joint Venture with Virtual Psychedelics Incorporated to Develop Multi-Sensory Pods for Clinical Psychedelic Use Cannabis Investing News
Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants Cannabis Investing News
Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab Cannabis Investing News
Rosen, A Leading Law Firm, Encourages Champignon Brands Inc. Investors with Losses to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Champignon Brands Inc. Investors With Losses to Secure Counsel Before Important June 9 Deadline in First Filed Securities Class Action Commenced by the Firm - SHRMF Psychedelics Investing
DEADLINE ALERT for DDD, DOX, SHRMF, and FGEN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders Psychedelics Investing
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Champignon Brands Inc. Psychedelics Investing
